SNN vs. BSX
Compare and contrast key facts about Smith & Nephew plc (SNN) and Boston Scientific Corporation (BSX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNN or BSX.
Correlation
The correlation between SNN and BSX is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNN vs. BSX - Performance Comparison
Key characteristics
SNN:
-0.13
BSX:
3.48
SNN:
-0.00
BSX:
4.70
SNN:
1.00
BSX:
1.64
SNN:
-0.07
BSX:
8.18
SNN:
-0.35
BSX:
34.81
SNN:
10.09%
BSX:
1.68%
SNN:
26.12%
BSX:
16.85%
SNN:
-55.20%
BSX:
-89.15%
SNN:
-45.31%
BSX:
-3.79%
Fundamentals
SNN:
$11.09B
BSX:
$133.28B
SNN:
$0.70
BSX:
$1.21
SNN:
36.34
BSX:
74.74
SNN:
0.42
BSX:
1.64
SNN:
$5.62B
BSX:
$15.91B
SNN:
$3.88B
BSX:
$10.71B
SNN:
$1.07B
BSX:
$3.73B
Returns By Period
In the year-to-date period, SNN achieves a -6.11% return, which is significantly lower than BSX's 52.27% return. Over the past 10 years, SNN has underperformed BSX with an annualized return of -1.10%, while BSX has yielded a comparatively higher 20.99% annualized return.
SNN
-6.11%
-2.55%
-0.04%
-4.40%
-10.04%
-1.10%
BSX
52.27%
-2.68%
15.36%
57.70%
14.22%
20.99%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNN vs. BSX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Smith & Nephew plc (SNN) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNN vs. BSX - Dividend Comparison
SNN's dividend yield for the trailing twelve months is around 3.01%, while BSX has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNN Smith & Nephew plc | 3.01% | 2.75% | 2.79% | 2.17% | 1.78% | 1.51% | 1.96% | 1.76% | 2.08% | 1.71% | 1.52% | 1.85% |
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
SNN vs. BSX - Drawdown Comparison
The maximum SNN drawdown since its inception was -55.20%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for SNN and BSX. For additional features, visit the drawdowns tool.
Volatility
SNN vs. BSX - Volatility Comparison
Smith & Nephew plc (SNN) and Boston Scientific Corporation (BSX) have volatilities of 4.37% and 4.59%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNN vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Smith & Nephew plc and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities